Bonzun AB

ST:BONZUN Sweden Healthcare Providers & Services
Market Cap
$29.12 Million
Skr326.69 Million SEK
Market Cap Rank
#45272 Global
#669 in Sweden
Share Price
Skr9.50
Change (1 day)
+3.15%
52-Week Range
Skr9.00 - Skr10.80
All Time High
Skr101.12
About

Bonzun AB (publ) operates as a healthcare company that provides Internet-based health services in Sweden. The company offers solutions for stress-related disorders. It also provides support services to the therapists who work with stress, cardiovascular disease, anxiety, relationship problems, etc. The company was formerly known as Papilly AB (publ) and changed its name to Bonzun AB (publ). Bonzu… Read more

Bonzun AB (BONZUN) - Net Assets

Latest net assets as of June 2024: Skr-13.19 Million SEK

Based on the latest financial reports, Bonzun AB (BONZUN) has net assets worth Skr-13.19 Million SEK as of June 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr788.00K) and total liabilities (Skr13.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr-13.19 Million
% of Total Assets -1674.37%
Annual Growth Rate 94.96%
5-Year Change 10935.27%
10-Year Change 552.77%
Growth Volatility 1743.17

Bonzun AB - Net Assets Trend (2012–2023)

This chart illustrates how Bonzun AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Bonzun AB (2012–2023)

The table below shows the annual net assets of Bonzun AB from 2012 to 2023.

Year Net Assets Change
2023-12-31 Skr39.80 Million +290.91%
2022-12-31 Skr10.18 Million -65.57%
2021-12-31 Skr29.58 Million +1198.78%
2020-12-31 Skr2.28 Million +531.38%
2019-12-31 Skr360.68K -95.10%
2018-12-31 Skr7.37 Million +264.72%
2017-12-31 Skr-4.47 Million -591.20%
2016-12-31 Skr910.39K -84.68%
2015-12-31 Skr5.94 Million -2.54%
2014-12-31 Skr6.10 Million +302.47%
2013-12-31 Skr1.52 Million +5778.98%
2012-12-31 Skr25.77K --

Equity Component Analysis

This analysis shows how different components contribute to Bonzun AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 2423000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Common Stock Skr18.67 Million 46.90%
Other Comprehensive Income Skr-145.03 Million -364.37%
Other Components Skr166.16 Million 417.46%
Total Equity Skr39.80 Million 100.00%

Bonzun AB Competitors by Market Cap

The table below lists competitors of Bonzun AB ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Bonzun AB's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 10,182,000 to 39,802,000, a change of 29,620,000 (290.9%).
  • Net income of 13,884,375 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 145,026,000.
  • Other factors increased equity by 160,761,625.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income Skr13.88 Million +34.88%
Other Comprehensive Income Skr-145.03 Million -364.37%
Other Changes Skr160.76 Million +403.9%
Total Change Skr- 290.91%

Book Value vs Market Value Analysis

This analysis compares Bonzun AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 29.71x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 1.38x to 29.71x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 Skr6.90 Skr9.50 x
2014-12-31 Skr27.77 Skr9.50 x
2015-12-31 Skr23.60 Skr9.50 x
2016-12-31 Skr3.13 Skr9.50 x
2017-12-31 Skr-11.56 Skr9.50 x
2018-12-31 Skr2.14 Skr9.50 x
2019-12-31 Skr0.09 Skr9.50 x
2020-12-31 Skr0.38 Skr9.50 x
2021-12-31 Skr0.05 Skr9.50 x
2022-12-31 Skr0.30 Skr9.50 x
2023-12-31 Skr0.32 Skr9.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Bonzun AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 34.88%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 507.47%
  • • Asset Turnover: 0.06x
  • • Equity Multiplier: 1.17x
  • Recent ROE (34.88%) is above the historical average (-591.49%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 -405.60% -12288.60% 0.01x 2.68x Skr-6.30 Million
2014 -87.34% 0.00% 0.00x 1.59x Skr-5.94 Million
2015 -123.22% -11933.31% 0.00x 2.24x Skr-7.92 Million
2016 -1145.87% -62032.29% 0.00x 17.31x Skr-10.52 Million
2017 0.00% -2271.55% 0.07x 0.00x Skr-20.13 Million
2018 -157.06% -1063.74% 0.11x 1.40x Skr-12.31 Million
2019 -3706.02% -1013.46% 0.20x 18.70x Skr-13.40 Million
2020 -455.38% -1868.89% 0.14x 1.79x Skr-10.60 Million
2021 -34.80% -2863.13% 0.01x 1.64x Skr-13.25 Million
2022 -426.00% -3983.01% 0.04x 2.69x Skr-44.39 Million
2023 34.88% 507.47% 0.06x 1.17x Skr9.90 Million

Industry Comparison

This section compares Bonzun AB's net assets metrics with peer companies in the Healthcare Providers & Services industry.

No peer company data available for comparison.